Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points
Authors:
Open Access
- 14 March 2023
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 45 (3) , 198-209
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bowel DisordersGastroenterology, 2016
- Design of Treatment Trials for Functional Gastrointestinal DisordersGastroenterology, 2016
- Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IVGastroenterology, 2016
- Characterization of symptoms in irritable bowel syndrome with mixed bowel habit patternNeurogastroenterology & Motility, 2013
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without ConstipationNew England Journal of Medicine, 2011
- Predictors of Patient-Assessed Illness Severity in Irritable Bowel SyndromeAmerican Journal of Gastroenterology, 2008
- Functional Bowel DisordersGastroenterology, 2006
- Irritable bowel syndrome in the United States: prevalence, symptom patterns and impactAlimentary Pharmacology & Therapeutics, 2005
- Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled trialsClinical Gastroenterology and Hepatology, 2004
- Functional bowel disorders and functional abdominal painGut, 1999